Research Article

Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS)

Table 2

Details of differential compounds between KST and M in the negative ion mode.

Rt (min)CompoundsFormula[M − H]experimental[M − H]calculatedError (ppm)MS/MS

7.68ButalbitalC11H16N2O3223.109223.10880.8180, 153
31.136-(3-Hydroxypentan-3-yl)-2,2,6-trimethyloxane-3-carboxylic acidC14H26O4257.1759257.17580.3239, 195
57.88Stearic acidC18H36O2283.2641283.2643−0.50265
7.683′-Azido-2′,3′-dideoxyguanosineC10H12N8O3291.0962291.0960.8291, 223, 180
18.24[6]-GingerolC17H26O4293.1762293.17581.30236, 221, 205, 192, 177
39.1UnknownC14H24N6O2307.1892307.18881.3259, 239, 102
7.662-({5-Chloro-2-[(2-fluorobenzyl)oxy]benzyl}amino)ethanolC16H17NO2FCl308.0863308.08591.3223, 180
51.95UnknownC14H26N6O2309.2045309.20440.2241, 104
44.5Octadecanedioic acidC18H34O4313.2385313.23840.2295, 251
47.532-Dodecylbenzenesulfonic acidC18H30O3S325.1843325.18430293, 183
27.8212-[2-(3-Carboxypropoxy)phenoxy]dodecanoic acidC22H34O6393.2282393.2283−0.2257, 231
37.12Glycodeoxycholic acidC26H43NO5448.3062448.3068−1.4404, 74
29.67Glycocholic acidC26H43NO6464.3013464.3018−1402, 74
4.19UnknownC19H34N6O10505.2261505.22643.00306, 241, 207
60.822-Deoxy-4-O-[(2E,4R,6E,8E,10S,11R,12S)-11-hydroxy-2,4,6,8,10,12-hexamethyl-5-oxo-2,6,8-docosatrienoyl]-D-erythro-pentonic acidC33H56O8579.3901579.3902−0.2403, 175, 113
46.14UnknownC26H48N7O9P632.3177632.3178−0.2504, 279, 112
61.95GalactosylceramideC40H77NO8698.558698.55760.5536, 426, 290, 179, 89
45.06UnknownC28H59N3O13P4768.2929768.29260.4248, 180, 112